← FDA Drug Approvals (Drugs@FDA)

ARRANON

NDA · New Drug Application · Sponsor: SANDOZ · Approved 2005-10-28

Drug application

FDA Application #

NDA021877

Application type

New Drug Application

Brand name

ARRANON

Generic name

NELARABINE

Active ingredients

NELARABINE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

SANDOZ

Manufacturer

Sandoz Inc

First approval

2005-10-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown